PDA's Training Course Answers Questions About Single Use Systems

Single Use Systems for Manufacturing of Parenteral Products

BETHESDA, Md., Sept. 19, 2013 /PRNewswire-USNewswire/ -- When the topic of single use systems comes up among pharmaceutical manufacturers, there seems to be more questions than answers.

(Logo: http://photos.prnewswire.com/prnh/20130226/DC66667LOGO )

On October 23 and 24, 2014, the PDA Training and Research Institute is offering a two day course that will give you a comprehensive guide to implementing a single use system. It includes how to implement a well-designed manufacturing strategy that will show you how a single use system can reduce costs and ensure quality products. 

You'll also be able to get your hands on products to see how they actually work and decide for yourself whether these would fit into your manufacturing process.

The course is offered at PDA's Training and Research Institute in Bethesda, Maryland and taught by Robert Repetto, senior director, external affairs for Pfizer, Inc. He leads the company's contract manufacturing strategy for biosimilars. He chairs PDA's global task force for single use systems.

About PDA
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its more than 9,500 members worldwide. PDA's Annual Meeting will be held April 7-9, 2014 in San Antonio, Texas. For information, visit www.pda.org and follow PDA on LinkedIn.

Press Contact
Amelia Townsend
Director of Marketing Services, Parenteral Drug Association® (PDA)
T: 301-656-5900, ext. 153
Email: [email protected]

SOURCE Parenteral Drug Association

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED